Dyne Therapeutics, Inc. DYN
18.53 USD +0.48 (+2.66%)
Nov 4, 2026, 11:07 AM EST
17.94 Day range 18.68
14.00 52-week range 27.31
- YTD
- -5.27%
- 1 year
- -13.89%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -468.18M | -343.89M | -242.16M | -170.96M | -150.03M | |
| -446.21M | -317.42M | -235.94M | -168.10M | -149.29M | |
| -3.47 | -3.37 | -3.95 | -3.23 | -2.93 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 893.37M | 435.45M | 123.94M | 174.47M | 203.14M | |
| 1.19B | 691.23M | 165.08M | 306.32M | 425.66M | |
| 214.83M | 61.40M | 73.79M | 53.96M | 57.47M | |
| 169.20M | 23.99M | 27.41M | 30.48M | 32.64M | |
| 972.13M | 629.84M | 91.29M | 252.36M | 368.20M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -403.21M | -292.37M | -188.16M | -153.65M | -119.56M | |
| -28.75M | -204.08M | 83.31M | 87.20M | -137.89M | |
| 890.31M | 809.89M | 54.32M | 37.39M | 157.82M | |
| -20.71M | -2.38M | -729.00K | -3.07M | -3.62M | |
| 458.35M | 313.45M | -50.52M | -29.05M | -99.63M |